Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Network pharmacology approach to screen hypoglycemic extracts from Coptidis rhizoma and study their targets and pathways

Liu Xiao¹, Yi Li², Xin-guo Liu², Quan-wei Yang², Lei Yang³, He-gui Huang², Lei Huang², Ming Wei⁴

¹Wuhan No. 1 Hospital, Wuhan No. 1 Hospital, Wuhan, 430022, China; ²Pharmacy Department, Wuhan No. 1 Hospital, Wuhan, 430022, China; ³Pharmacy Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, 410007, China; ⁴Physical Examination Center, Wuhan No. 3 Hospital, Wuhan 430060, China.

For correspondence:- Ming Wei Email: wm15307117271@163.com Tel:+862768894785

Accepted: 23 June 2022 Published: 31 July 2022

Citation: Xiao L, Li Y, Liu X, Yang Q, Yang L, Huang H, et al. Network pharmacology approach to screen hypoglycemic extracts from Coptidis rhizoma and study their targets and pathways. Trop J Pharm Res 2022; 21(7):1493-1498 doi: 10.4314/tjpr.v21i7.20

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To screen the hypoglycemic active ingredients of Coptidis rhizoma, and study their targets as well as signal pathways via network pharmacology.

Methods: Fifty-nine ingredients of Coptidis rhizoma were screened. Their targets were confirmed by comparing with the hypoglycemic targets in DrugBank databases. The relationship between ingredients and targets was revealed through String database. The ingredient-target-passageway network was constructed. Coptidis rhizoma was soaked in boiling water and concentrated. Rat models were rendered diabetic by the administration of streptozotocin (STZ) intraperitoneal injection. The hyperglycemic rats received Coptidis rhizoma extract (0.40 g/kg, once a day by gavage).

Results: After four weeks of treatment, the blood glucose levels (BG) of all treated hyperglycemic rats decreased (p < 0.05). Twenty-four hypoglycemic active compounds were obtained after screening the extract of Coptidis rhizome via network pharmacology. These active compounds activated 13 targets, including D (2) dopamine receptor (DRD2), Insulin-like growth factor 1 receptor (IGF1R), 5-hydroxytryptamine receptor 2C (HTR2C), 5-hydroxytryptamine receptor 3A (HTR3A) and sodium-dependent noradrenaline transporter (SLC6A2). These targets were involved in 141 pathways, e.g., cAMP signaling pathway, chemokine signaling pathway, Rap1 signaling pathway, estrogen signaling pathway, and apelin signaling pathway.

Conclusion: Coptidis rhizoma contains several active compounds that exhibit good hypoglycemic effects. Thus, there is a need for human studies on the hypoglycemic effects of Coptidis rhizome extracts.

Keywords: Coptidis rhizoma, Hypoglycemic effects, Network pharmacology, D (2) dopamine receptor (DRD2), Insulin-like growth factor 1 receptor